Last deal

$48.83M
Local Amount - INR 4.1B

Amount

Venture - Series Unknown

Stage

30.01.2023

Date

1

all rounds

$48.83M

Total amount

Financing round

General

About Company
Enzene Biosciences is a technology-driven biotech company that develops and manufactures cost-effective biosimilars.

Industry

Sector :

Subsector :

Keywords :

Number of employees

Company Type

For Profit

Last funding type

Venture - Series Unknown

IPO status

Private

Description

Based in Pune, India, Enzene is focused on biosimilars, phytopharma, peptide, and regenerative business. The company has an R&D center in Bhosari, Pune, which has technical expertise in cloning, process development, and novel formulation development. Enzene plans to set up a large-scale cGMP production facility in MIDC, Chakan, Pune, to satisfy its growing portfolio of biosimilars, which will include mammalian cell culture production, microbial, and drug product filling. The company aims to enhance global healthcare by broadening the footprint of its innovative technologies through strategic global alliances.
Contacts

Contact Email

Phone number

Social url

Similar Companies
1000
Bioneer A/S

Bioneer A/S

Danish tech company offering custom development and analytical services to drug and diagnostic companies.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Pharmaceuticals, Life Science

Location

2970 Hørsholm, Denmark
Protein Technologies

Protein Technologies

Protein Technologies Ltd. (PTL) is a biotech company that provides contract research services to the biotech industry.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Manchester, UK
Genencor International

Genencor International

Genencor is a biotechnology company that provides biotechnological products.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Pharmaceuticals, Medical Device

Location

Palo Alto, CA, USA
Jotbody

Jotbody

Jotbody is an early-stage biotechnology company specializing in single-domain antibody discovery and production.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care

Location

New Territories, Hong Kong

Financials

Funding Rounds
1
1

Number of Funding Rounds

$48.83M

Money Raised

Their latest funding was raised on 30.01.2023. Their latest investor F-Prime Capital. Their latest round Venture - Series Unknown

Date 
Funding Round 
Investors 
Money Raised 
Lead 
30.01.2023
3
$48.83M
Local Amount - INR 4.1B
Alkem Laboratories

Alkem Laboratories

Alkem Labs develops and sells pharmaceutical products worldwide.

Sector

Pharmaceuticals and Biotechnology

Subsector

Pharmaceuticals

Location

Mumbai, Maharashtra, India

total rounds

1

total raised

$60M

count Of Investments

3
F-Prime Capital

F-Prime Capital

F-Prime Capital is a venture capital firm that invests in technology, healthcare and life sciences sectors in the United States and Europe.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Venture Capital, Financial Services, Health Care

Location

Cambridge, MA, USA

count Of Investments

358

count Of Exists

44
Eight Roads Ventures India

Eight Roads Ventures India

Eight Roads Ventures India supports innovative tech and healthcare companies globally.

Sector

General Industrials

Subsector

Diversified Industrials

Keywords

Health Care, Venture Capital, Information Technology

Location

Bengaluru, Karnataka, India

count Of Investments

22
Co-Investors
Investors
3
3

Number of lead investors

3

Number of investors

Investor 
Lead 
Round 
Partners 
Yes
Venture - Series Unknown
Yes
Venture - Series Unknown
Yes
Venture - Series Unknown
F-Prime Capital

F-Prime Capital

F-Prime Capital is a venture capital firm that invests in technology, healthcare and life sciences sectors in the United States and Europe.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Venture Capital, Financial Services, Health Care

Location

Cambridge, MA, USA

count Of Investments

358

count Of Exists

44
Ketan Patel

Ketan Patel

Prior to joining Fidelity Biosciences, Dr. Patel was an engagement manager in the MEDACorp consulting division of Leerink Swann & Company. While at MEDACorp, he worked for a broad spectrum of clients ranging from biotech to leading pharmaceutical and device companies. Dr. Patel advised clients on brand strategy, clinical development plans, and business development activities. Prior to this, he was a physician at Weill Cornell Medical Center-New York Presbyterian Hospital and Memorial-Sloan Kettering Cancer Center where he completed his internal medicine training. Dr. Patel is a graduate of Tufts University School of Medicine, where he received both his MD and MBA as part of that institution's Healthcare Management Program and was elected to the Alpha Omega Alpha Medical Honor Society. He completed his undergraduate studies in biology and economics with highest honors at Rutgers University.

current job

F-Prime Capital
F-Prime Capital
Alkem Laboratories

Alkem Laboratories

Alkem Labs develops and sells pharmaceutical products worldwide.

Sector

Pharmaceuticals and Biotechnology

Subsector

Pharmaceuticals

Location

Mumbai, Maharashtra, India

total rounds

1

total raised

$60M

count Of Investments

3
Eight Roads Ventures India

Eight Roads Ventures India

Eight Roads Ventures India supports innovative tech and healthcare companies globally.

Sector

General Industrials

Subsector

Diversified Industrials

Keywords

Health Care, Venture Capital, Information Technology

Location

Bengaluru, Karnataka, India

count Of Investments

22
Prem Pavoor

Prem Pavoor

Prem is a Managing Director at FIL Capital Advisors (India) Private Limited, where he focuses on sectors that include life sciences, healthcare, speciality chemicals and agriculture. Prem brings a cumulative 14 years of experience in management consulting, engineering consulting and technology research, both in the United States and in India. Most recently, Prem was an Engagement Manager with McKinsey & Company’s Pharmaceutical and Medical Products Practice in New Jersey, where he advised pharmaceutical/biotech, consumer goods and private equity clients on areas that included R&D, business development, post-merger integrations and manufacturing. Prior to McKinsey, Prem served as an engineering consultant to the Mitsubishi Chemical Corporation in Japan and to a drug delivery company, Alkermes, Inc., in Boston, on design and scale-up of manufacturing processes. Prem’s doctoral thesis work, performed at the Massachusetts Institute of Technology (MIT) and Brigham and Women’s Hospital (Boston), focused on enhancing the performance of medical implants. The work is the subject of several international peer-reviewed publications and a U.S. patent. Prem was awarded the 2004 MIT-OMNOVA award for Excellence in Polymer Research for his thesis contribution. Prem holds a Bachelors degree in Chemical Engineering from the Institute of Chemical Technology (formerly UDCT), Mumbai, a MS and Ph.D. in Chemical Engineering Practice from the Massachusetts Institute of Technology (MIT) and an MBA from MIT Sloan.

current job

Eight Roads Ventures
Eight Roads Ventures

People

Employee Profiles
3
Viral Shah

Viral Shah

Chief Financial Officer and Head Procurement

Himanshu Gadgil

Himanshu Gadgil

CSO & Whole-Time Director

Basudev N. Singh

Basudev N. Singh

Founder &Director

Activity

Recent News
2
News Timeline

The graph reveals the ratio (%) of positive news articles in a chosen time range

month